Show simple item record

dc.contributor.authorChen, Marceloen_US
dc.contributor.authorHuang, Yi-Lingen_US
dc.contributor.authorHuang, Yu-Chuenen_US
dc.contributor.authorShui, Irene M.en_US
dc.contributor.authorGiovannucci, Edwarden_US
dc.contributor.authorChen, Yen-Chingen_US
dc.contributor.authorChen, Yi-Ming Arthuren_US
dc.date.accessioned2014-07-07T18:13:15Z
dc.date.issued2014en_US
dc.identifier.citationChen, Marcelo, Yi-Ling Huang, Yu-Chuen Huang, Irene M. Shui, Edward Giovannucci, Yen-Ching Chen, and Yi-Ming Arthur Chen. 2014. “Genetic Polymorphisms of the Glycine N-Methyltransferase and Prostate Cancer Risk in the Health Professionals Follow-Up Study.” PLoS ONE 9 (5): e94683. doi:10.1371/journal.pone.0094683. http://dx.doi.org/10.1371/journal.pone.0094683.en
dc.identifier.issn1932-6203en
dc.identifier.urihttp://nrs.harvard.edu/urn-3:HUL.InstRepos:12406871
dc.description.abstractPurpose Glycine N-methyltransferase (GNMT) affects genetic stability by regulating the ratio of S-adenosylmethionine to S-adenosylhomocysteine, by binding to folate, and by interacting with environmental carcinogens. In Taiwanese men, GNMT was found to be a tumor susceptibility gene for prostate cancer. However, the association of GNMT with prostate cancer risk in other ethnicities has not been studied. It was recently reported that sarcosine, which is regulated by GNMT, increased markedly in metastatic prostate cancer. We hereby explored the association of GNMT polymorphisms with prostate cancer risk in individuals of European descent from the Health Professionals Follow-up Study (HPFS). Methods: A total of 661 incident prostate cancer cases and 656 controls were identified from HPFS. The GNMT short tandem repeat polymorphism 1 (STRP1), 4-bp insertion/deletion polymorphisms (INS/DEL) and the single nucleotide polymorphism rs10948059 were genotyped to test for their association with prostate cancer risk. Results: The rs10948059 T/T genotype was associated with a 1.62-fold increase in prostate cancer risk (95% confidence interval (CI): 1.18, 2.22) when compared with the C/C genotype. The STRP1 ≥16GAs/≥16GAs genotype was associated with decreased risk of prostate cancer when compared with the <16GAs/<16GAs genotype (odds ratio (OR) = 0.68; 95% CI: 0.46, 1.01). INS/DEL was not associated with prostate cancer risk. Haplotypes containing the rs10948059 T allele were significantly associated with increased prostate cancer risk. Conclusion: In men of European descent, the GNMT rs10948059 and STRP1 were associated with prostate cancer risk. Compared to the study conducted in Taiwanese men, the susceptibility GNMT alleles for prostate cancer had a reverse relationship. This study highlights the differences in allelic frequencies and prostate cancer susceptibility in different ethnicities.en
dc.language.isoen_USen
dc.publisherPublic Library of Scienceen
dc.relation.isversionofdoi:10.1371/journal.pone.0094683en
dc.relation.hasversionhttp://www.ncbi.nlm.nih.gov/pmc/articles/PMC4011739/pdf/en
dash.licenseLAAen_US
dc.subjectMedicine and Health Sciencesen
dc.subjectEpidemiologyen
dc.subjectGenetic Epidemiologyen
dc.subjectOncologyen
dc.subjectCancers and Neoplasmsen
dc.subjectGenitourinary Tract Tumorsen
dc.subjectProstate Canceren
dc.subjectUrologyen
dc.subjectProstate Diseasesen
dc.titleGenetic Polymorphisms of the Glycine N-Methyltransferase and Prostate Cancer Risk in the Health Professionals Follow-Up Studyen
dc.typeJournal Articleen_US
dc.description.versionVersion of Recorden
dc.relation.journalPLoS ONEen
dash.depositing.authorShui, Irene M.en_US
dc.date.available2014-07-07T18:13:15Z
dc.identifier.doi10.1371/journal.pone.0094683*
dash.authorsorderedfalse
dash.contributor.affiliatedShui, Irene
dash.contributor.affiliatedGiovannucci, Edward


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record